1,211 results on '"Henze G"'
Search Results
2. P02.105. Short term improvement of subject well-being after a single Rhythmical Massage: a prospective, randomized, controlled trial
3. P02.106. Eurhythmy Therapy in the aftercare of children and adolescents with brain tumors of the posterior fossa: a pilot study
4. Onkologie
5. Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR
6. A graph neural network framework for causal inference in brain networks
7. Onkologie – Knochenmarktransplantation
8. Onkologie — KMT
9. Dose Finding in Pediatric Patients
10. Onkologie — KMT
11. Low-intensity therapy cures over 40 % of children with rapid Flow-MRD responding ALL: the ALL-MB 2008 trial results
12. Onkologie/KMT
13. Efficacy and toxicity of dexamethasone vs methylprednisolone—long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002
14. Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment
15. Abschlusssymposium des Kompetenznetzes Pädiatrische Onkologie und Hämatologie
16. Treatment of Children with Relapsed Acute Lymphoblastic Leukemia Studies of the BFM Study Group
17. Risk Adapted Treatment in Childhood Acute Lymphoblastic Leukemia: Data from the Berlin-Frankfurt-Münster Group
18. Similar Outcome in Boys with Isolated and Combined Testicular Acute Lymphoblastic Leukemia Relapse After Stratified BFM Salvage Therapy
19. Interim Results of a Phase II Study with Idarubicin in Relapsed Childhood Acute Lymphoblastic Leukemia
20. Salvage Therapy of Childhood ALL: Prognosis of Marrow Relapse After Intensive Front-line Therapy
21. Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma—results for dedicated assessment criteria in a blinded dual-centre read
22. Chemotherapy for Relapsed Childhood Acute Lymphoblastic Leukemia: Results of the BFM Study Group
23. Cytostatic Drug Resistance in Childhood Relapsed Acute Lymphoblastic Leukemia
24. Muskuloskelettale Schmerzen bei Kindern und Jugendlichen -Ein Algorithmus zur differenzialdiagnostischen Abklärung eines onkologischen Leitsymptoms (S2)
25. Organisationsstruktur der Pädiatrischen Onkologie und derzeitiger Stand der Qualitätssicherung
26. Grundlagen der Therapie von Tumoren und malignen Systemerkrankungen bei Kindern und Jugendlichen
27. Phase I/II Trial with Low-Dose Interleukin-2 and Interferon-Gamma in Children with High-Risk Leukemia and Non-Hodgkin’s Lymphoma After Autologous Bone Marrow Transplantation
28. Specific and Sensitive Detection of Cytomegalovirus DNA in Clinical Specimens by Polymerase Chain Reaction
29. Allogeneic Bone Marrow Transplantation in Childhood Leukemia: Results and Strategies in the Federal Republic of Germany
30. BFM Group Treatment Results in Relapsed Childhood Acute Lymphoblastic Leukemia
31. Results and Significance of Six Randomized Trials in Four Consecutive ALL-BFM Studies
32. Impact of Early Intensive Reinduction Therapy on Event-Free Survival in Children with Low-Risk Acute Lymphoblastic Leukemia
33. Central Nervous System Relapse Prevention in 1165 Standard-Risk Children with Acute Lymphoblastic Leukemia in Five BFM Trials
34. Risk of CNS Relapse After Systemic Relapse of Childhood Acute Lymphoblastic Leukemia
35. Immunoglobulin and T-Cell Receptor Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma
36. Higher fibrinogen concentrations for reduction of transfusion requirements during major paediatric surgery: A prospective randomised controlled trial†
37. Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia
38. Register of Radioactively Contaminated Sites — Example of the Suspected Area 'Freital'
39. Autologous and Allogeneic Bone Marrow Transplantation After Identical High-Dose Chemo-Radiotherapy in Children with Relapsed ALL
40. Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment
41. Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL
42. Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia
43. Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
44. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
45. Intraossäre Infusion: Eine wichtige Technik auch für die Kinderanästhesie
46. Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation
47. Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia
48. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials
49. Beitrag des Kompetenznetzes Pädiatrische Onkologie und Hämatologie zur Verbesserung der Versorgung und Forschung bei pädiatrischen Patienten mit malignen Tumoren
50. Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.